Resources

Connecting the Data Wires

Medicines Discovery Catapult welcomes new Board Members

This week the Medicines Discovery Catapult has welcomed three new Board Members.

What makes a drug discovery consortium successful?

Supporting the race for treatments new collaboration launched to drive understanding of COVID-19

Medicines Discovery Catapult, Retrogenix and Peak Proteins collaborate to identify target receptors for COVID-19.

Quantification of protein glycation using vibrational spectroscopy

Supporting the raceBritain’s biggest network of diagnostic labs are completed in 5 weeksfor treatments new collaboration launched to drive understanding of COVID-19

Sites in Milton Keynes, Glasgow and Alderley Park in Cheshire are now live and are already testing thousands of patient samples for coronavirus (COVID-19) each day.

Testing capacity increases as second Lighthouse Lab becomes fully operational

The second mega-lab at Alderley Park in Cheshire has begun to test thousands of patient samples a day for coronavirus.

Medicines Discovery Catapult, at Alderley Park, in partnership with industry and academia, advancing COVID-19 testing capacity

The Government announced the establishment of large scale national COVID-19 hub laboratories across the UK.

Guiding health researchers through the approvals needed to obtain NHS data

An introduction to the application of AI technology in the generation of insights from real-world health data sources